These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22166520)

  • 1. Premature atherosclerosis in patients with acquired immunodeficiency syndrome.
    Zeng Y; Ye YC; Luo L; Qiu ZF; Han Y; Li XM; Fang Q; Zhang SY; Li TS
    Chin Med J (Engl); 2010 Dec; 123(23):3396-9. PubMed ID: 22166520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased arterial stiffness in HIV-infected children: risk factors and antiretroviral therapy.
    Charakida M; Loukogeorgakis SP; Okorie MI; Masi S; Halcox JP; Deanfield JE; Klein NJ
    Antivir Ther; 2009; 14(8):1075-9. PubMed ID: 20032537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection.
    Schillaci G; De Socio GV; Pirro M; Savarese G; Mannarino MR; Baldelli F; Stagni G; Mannarino E
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2381-5. PubMed ID: 16123321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
    Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
    Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients.
    Palacios R; Santos J; García A; Castells E; González M; Ruiz J; Márquez M
    HIV Med; 2006 Jan; 7(1):10-5. PubMed ID: 16313287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
    Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
    AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
    Braitstein P; Zala C; Yip B; Brinkhof MW; Moore D; Hogg RS; Montaner JS
    J Infect Dis; 2006 Jan; 193(2):259-68. PubMed ID: 16362890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitor treatment effect on aortic stiffness in normotensive patients with human immunodeficiency virus infection.
    Lopez-Sublet M; Honoré P; Bentata M; Bratis C; Rouges F; Krivitzky A; Dhôte R; Mourad JJ
    J Mal Vasc; 2012 Jul; 37(4):179-85. PubMed ID: 22698629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the atherosclerotic process accentuated under conditions of HIV infection, antiretroviral therapy, and protease inhibitor exposure? Meta-analysis of the markers of arterial structure and function.
    Sun D; Wu Y; Yuan Y; Wang Y; Liu W; Yang J
    Atherosclerosis; 2015 Sep; 242(1):109-16. PubMed ID: 26188532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in human immunodeficiency virus-positive subjects: prevalence, phenotype, and related alterations in arterial structure and function.
    Maloberti A; Giannattasio C; Dozio D; Betelli M; Villa P; Nava S; Cesana F; Facchetti R; Giupponi L; Castagna F; Sabbatini F; Bandera A; Gori A; Grassi G; Mancia G
    Metab Syndr Relat Disord; 2013 Dec; 11(6):403-11. PubMed ID: 23885973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients].
    Li WJ; Dai Y; Han Y; Qiu ZF; Xie J; Zuo LY; Li YL; Li TS
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1318-22. PubMed ID: 21756757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
    Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
    Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
    Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy.
    Sevastianova K; Sutinen J; Westerbacka J; Ristola M; Yki-Järvinen H
    Antivir Ther; 2005; 10(8):925-35. PubMed ID: 16430198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.